tiprankstipranks
Trending News
More News >
Aldeyra Therapeutics (ALDX)
NASDAQ:ALDX
US Market

Aldeyra Therapeutics (ALDX) Income Statement

Compare
1,686 Followers

Aldeyra Therapeutics Income Statement

Last quarter (Q3 2025), Aldeyra Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Aldeyra Therapeutics's net income was $-7.69M. See Aldeyra Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -56.22K
Operating Expenses
$ 60.12M$ 42.79M$ 62.68M$ 56.22M$ 34.61M
Depreciation and Amortization
$ 249.62K$ 262.78K$ 258.71K$ 264.18K$ 56.22K
EBITDA
$ -53.68M$ -35.21M$ -60.07M$ -55.77M$ -36.07M
Operating Income
$ -60.12M$ -42.79M$ -62.68M$ -56.22M$ -34.67M
Other Income/Expenses
$ 4.27M$ 5.25M$ 655.35K$ -1.56M$ -3.37M
Pretax Income
$ -55.85M$ -37.54M$ -62.02M$ -57.78M$ -38.03M
Net Income
$ -55.85M$ -37.54M$ -62.02M$ -57.78M$ -37.55M
Per Share Metrics
Basic EPS
$ -0.94$ -0.64$ -1.06$ -1.07$ -1.11
Diluted EPS
$ -0.94$ -0.64$ -1.06$ -1.07$ -1.11
Weighted Average Shares Outstanding
59.48M 58.94M 58.41M 54.04M 33.97M
Weighted Average Shares Outstanding (Diluted)
59.48M 58.94M 58.41M 54.04M 33.97M
Currency in USD

Aldeyra Therapeutics Earnings and Revenue History